Nataraj Kalyanaraman

Nataraj Kalyanaraman is an accomplished professional with extensive experience in drug development, having served as Vice President and Head of Drug Development at Bristol Myers Squibb from September 2019 to July 2023. In addition to this role, Kalyanaraman held positions as Vice President of Global Drug Development Strategy & Capabilities and Executive Director of Global Drug Development Operations at Bristol Myers Squibb. Prior to this, Kalyanaraman worked at PwC from July 2013 to February 2017 as Manager and Senior Associate and began a career at Amgen from March 2007 to June 2013, progressing through various scientific roles. Kalyanaraman holds degrees from UCLA Anderson School of Management and the University of Minnesota.